BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38522235)

  • 1. Empagliflozin mitigates cardiac hypertrophy through cardiac RSK/NHE-1 inhibition.
    Chen S; Overberg K; Ghouse Z; Hollmann MW; Weber NC; Coronel R; Zuurbier CJ
    Biomed Pharmacother; 2024 May; 174():116477. PubMed ID: 38522235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed ischaemic contracture onset by empagliflozin associates with NHE1 inhibition and is dependent on insulin in isolated mouse hearts.
    Uthman L; Nederlof R; Eerbeek O; Baartscheer A; Schumacher C; Buchholtz N; Hollmann MW; Coronel R; Weber NC; Zuurbier CJ
    Cardiovasc Res; 2019 Aug; 115(10):1533-1545. PubMed ID: 30649212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-target effects of sodium-glucose co-transporter 2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart.
    Chung YJ; Park KC; Tokar S; Eykyn TR; Fuller W; Pavlovic D; Swietach P; Shattock MJ
    Cardiovasc Res; 2021 Dec; 117(14):2794-2806. PubMed ID: 33135077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression.
    Abdulrahman N; Ibrahim M; Joseph JM; Elkoubatry HM; Al-Shamasi AA; Rayan M; Gadeau AP; Ahmed R; Eldassouki H; Hasan A; Mraiche F
    Mol Cell Biochem; 2022 Jun; 477(6):1865-1872. PubMed ID: 35334035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Na+/H+ exchanger isoform 1 induced cardiomyocyte hypertrophy involves activation of p90 ribosomal s6 kinase.
    Jaballah M; Mohamed IA; Alemrayat B; Al-Sulaiti F; Mlih M; Mraiche F
    PLoS One; 2015; 10(4):e0122230. PubMed ID: 25830299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Na
    Abdulrahman N; Jaspard-Vinassa B; Fliegel L; Jabeen A; Riaz S; Gadeau AP; Mraiche F
    Physiol Genomics; 2018 May; 50(5):332-342. PubMed ID: 29473817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na
    Uthman L; Baartscheer A; Bleijlevens B; Schumacher CA; Fiolet JWT; Koeman A; Jancev M; Hollmann MW; Weber NC; Coronel R; Zuurbier CJ
    Diabetologia; 2018 Mar; 61(3):722-726. PubMed ID: 29197997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting p90 ribosomal S6 kinase prevents (Na+)-H+ exchanger-mediated cardiac ischemia-reperfusion injury.
    Maekawa N; Abe J; Shishido T; Itoh S; Ding B; Sharma VK; Sheu SS; Blaxall BC; Berk BC
    Circulation; 2006 May; 113(21):2516-23. PubMed ID: 16717153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: potential relevance to prevention of cardiovascular events.
    Spigoni V; Fantuzzi F; Carubbi C; Pozzi G; Masselli E; Gobbi G; Solini A; Bonadonna RC; Dei Cas A
    Cardiovasc Diabetol; 2020 Apr; 19(1):46. PubMed ID: 32264868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Na+/H+ exchanger isoform 1-induced osteopontin expression facilitates cardiomyocyte hypertrophy.
    Mohamed IA; Gadeau AP; Fliegel L; Lopaschuk G; Mlih M; Abdulrahman N; Fillmore N; Mraiche F
    PLoS One; 2015; 10(4):e0123318. PubMed ID: 25884410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained intracellular acidosis activates the myocardial Na(+)/H(+) exchanger independent of amino acid Ser(703) and p90(rsk).
    Karki P; Coccaro E; Fliegel L
    Biochim Biophys Acta; 2010 Aug; 1798(8):1565-76. PubMed ID: 20471361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for direct regulation of myocardial Na+/H+ exchanger isoform 1 phosphorylation and activity by 90-kDa ribosomal S6 kinase (RSK): effects of the novel and specific RSK inhibitor fmk on responses to alpha1-adrenergic stimulation.
    Cuello F; Snabaitis AK; Cohen MS; Taunton J; Avkiran M
    Mol Pharmacol; 2007 Mar; 71(3):799-806. PubMed ID: 17142297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RSK Inhibitor BIX02565 Limits Cardiac Ischemia/Reperfusion Injury.
    Shi X; O'Neill MM; MacDonnell S; Brookes PS; Yan C; Berk BC
    J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):177-86. PubMed ID: 26130615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
    Arow M; Waldman M; Yadin D; Nudelman V; Shainberg A; Abraham NG; Freimark D; Kornowski R; Aravot D; Hochhauser E; Arad M
    Cardiovasc Diabetol; 2020 Jan; 19(1):7. PubMed ID: 31924211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin.
    Quagliariello V; De Laurentiis M; Rea D; Barbieri A; Monti MG; Carbone A; Paccone A; Altucci L; Conte M; Canale ML; Botti G; Maurea N
    Cardiovasc Diabetol; 2021 Jul; 20(1):150. PubMed ID: 34301253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p90(RSK)s mediate the activation of ribosomal RNA synthesis by the hypertrophic agonist phenylephrine in adult cardiomyocytes.
    Zhang Z; Liu R; Townsend PA; Proud CG
    J Mol Cell Cardiol; 2013 Jun; 59():139-47. PubMed ID: 23510923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hypertrophic effect of Na
    Riaz S; Abdulrahman N; Uddin S; Jabeen A; Gadeau AP; Fliegel L; Mraiche F
    Eur J Pharmacol; 2020 Dec; 888():173420. PubMed ID: 32781168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na+/H+ exchanger 1: persistent inhibition under various experimental conditions.
    Zuurbier CJ; Baartscheer A; Schumacher CA; Fiolet JWT; Coronel R
    Cardiovasc Res; 2021 Dec; 117(14):2699-2701. PubMed ID: 33792689
    [No Abstract]   [Full Text] [Related]  

  • 19. Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy.
    Li J; Kritzer MD; Michel JJ; Le A; Thakur H; Gayanilo M; Passariello CL; Negro A; Danial JB; Oskouei B; Sanders M; Hare JM; Hanauer A; Dodge-Kafka K; Kapiloff MS
    Circ Res; 2013 Jan; 112(1):128-39. PubMed ID: 22997248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of ERK-RSK cascade in phenylephrine-induced phosphorylation of GATA4.
    Li T; Liu Z; Hu X; Ma K; Zhou C
    Biochim Biophys Acta; 2012 Feb; 1823(2):582-92. PubMed ID: 22227582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.